George Scangos, president and CEO of Vir Biotechnology, describes how the biotech industry has changed over the past several decades. Advances in both the speed of genetic research and the capabilities of data science, as well as some prominent successes, he finds, have accelerated biotech investments and innovation.
Related
Nicole Diaz,
Snap Inc.
How to Build an Ethical Company [Entire Talk]
Ethics is a strategic imperative, not a nice-to-have extra.
Nicole Diaz,
Snap Inc.
How to Build an Ethical Company [Entire Talk]
Ethics is a strategic imperative, not a nice-to-have extra.
Jannick Malling,
Public.com
Social Fintech [Entire Talk]
Thoughtful product design can transform highly regulated industries.
Jannick Malling,
Public.com
Social Fintech [Entire Talk]
Thoughtful product design can transform highly regulated industries.
Rudy Cline-Thomas,
Mastry
Andre Iguodala,
Miami Heat
Bridging the Gap Between Sports and Tech [Entire Talk]
Athletes are increasingly making an impact as tech investors.
Rudy Cline-Thomas,
Mastry
Andre Iguodala,
Miami Heat
Bridging the Gap Between Sports and Tech [Entire Talk]
Athletes are increasingly making an impact as tech investors.
